NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia - NICE TAG TA426

Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemia - NICE TAG TA426

1.1Imatinib is recommended as an option for untreated, chronic-phase Philadelphia-chromosome-positive chronic myeloid leukaemia in adults.

1.2Dasatinib and nilotinib are recommended, within their marketing authorisations, as options for untreated chronic-phase Philadelphia-chromosome-positive chronic myeloid leukaemia in adults. The drugs are recommended only if the companies provide them with the discounts agreed in the relevant patient access schemes.

https://www.nice.org.uk/guidance/ta426

Site by Devopa
© Copyright 2019 NHS. All rights reserved.